Dr. Shrilaxmi Desiraju – Founder & CEO
PhD and MBA technopreneur with 22+ years of expertise in pharmaceutical and nutraceutical R&D commercialization, strategic partnerships, and patented formulation science.
Background & Expertise
Dr. Shrilaxmi Desiraju brings over two decades of cross-functional leadership in pharma and nutraceutical innovation. With a PhD in formulation science and an MBA in technology management, she has led multiple product commercialization programmes from early-stage R&D through global regulatory approval and market launch. Her work spans probiotic stabilisation, functional ingredient delivery systems, and IP-driven formulation strategies.
Role at Probiota Innovations
As Founder & CEO of Probiota Innovations, Dr. Desiraju leads the company's scientific vision and R&D strategy. She oversees the development and commercialization of patented probiotic stabilisation technologies, formulation science programmes, and the technical partnerships that enable brands to manufacture advanced functional gummies at scale.
Key Focus Areas
- ●Probiotic heat-stability and pH-resistant formulation science
- ●Patented encapsulation and stabilisation technologies
- ●R&D commercialization and IP strategy
- ●Regulatory compliance across US-FDA, EU, Health Canada, and TGA frameworks
- ●Active ingredient delivery in pectin-based gummy matrices
- ●Strategic partnerships and licensing for nutraceutical innovation